Evidence map›Paper›PMID 31088904›Full record

ArticleG3 (Bethesda, Md.)2019

Restriction of Cellular Plasticity of Differentiated Cells Mediated by Chromatin Modifiers, Transcription Factors and Protein Kinases.

Dylan P Rahe, Oliver Hobert

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Review
  8. DOT-1.1 (DOT1L) deficiency inBBA advances · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The C. elegans Hypertonic Stress Response: Big Insights from Shrinking Worms.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2021
    Review
  14. Article
  15. Cells · 2020
    Article
  16. Review
  17. Frontiers in genetics · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dylan P RaheDepartment of Biological Sciences, Howard Hughes Medical Institute, Columbia University, New York, NY.ORCID 0000-0001-7727-5561
Oliver HobertDepartment of Biological Sciences, Howard Hughes Medical Institute, Columbia University, New York, NY or38@columbia.edu.ORCID 0000-0002-7634-2854
Columbia University · US

Funding

Generating neurons through cellular reprogrammingR21NS076191 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOBERT, OLIVER · 2011 to 2012
$434k
Cell fate restriction and reprogramming in Caenorhabditis elegansF31NS080435 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI RAHE, DYLAN P · 2012 to 2014
$123k
Howard Hughes Medical InstituteNINDS NIH HHS F31 NS080435NINDS NIH HHS R21 NS076191
6 · The paper itself

Abstract

Ectopic expression of master regulatory transcription factors can reprogram the identity of specific cell types. The effectiveness of such induced cellular reprogramming is generally greatly reduced if the cellular substrates are fully differentiated cells. For example, in the nematode

Indexed as

Amino Acid SequenceAnimalsCaenorhabditis elegansCell DifferentiationCell PlasticityCellular ReprogrammingChromatinComputational BiologyEpidermisGene Expression RegulationHistonesHumansIn Situ Hybridization, FluorescenceMultigene FamilyMutagenesisMutationChromatinHistonesProtein KinasesTranscription FactorsUbiquitin-Specific ProteasesUSP48 protein, humanC. eleganscellular fateplasticitytranscription factor

Identifiers

PMID31088904
PMCPMC6643894
OpenAlexW2946219536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.